Literature DB >> 12672227

Identification of N,N-disubstituted phenylalanines as a novel class of inhibitors of hepatitis C NS5B polymerase.

Laval Chan1, T Jagadeeswar Reddy, Mélanie Proulx, Sanjoy K Das, Oswy Pereira, Wuyi Wang, Arshad Siddiqui, Constantin G Yannopoulos, Carl Poisson, Nathalie Turcotte, Alexandre Drouin, M Hicham Alaoui-Ismaili, Richard Bethell, Martine Hamel, Lucille L'Heureux, Darius Bilimoria, Nghe Nguyen-Ba.   

Abstract

The HCV NS5B RNA dependent RNA polymerase plays an essential role in viral replication. The discovery of a novel class of inhibitors based on an N,N-disubstituted phenylalanine scaffold and structure-activity relationships studies to improve potency are described.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12672227     DOI: 10.1021/jm0340400

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  16 in total

1.  Synergy of small molecular inhibitors of hepatitis C virus replication directed at multiple viral targets.

Authors:  David L Wyles; Kelly A Kaihara; Florin Vaida; Robert T Schooley
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

2.  Inhibitory effect of 2'-substituted nucleosides on hepatitis C virus replication correlates with metabolic properties in replicon cells.

Authors:  Joanne E Tomassini; Krista Getty; Mark W Stahlhut; Sung Shim; Balkrishen Bhat; Anne B Eldrup; Thazha P Prakash; Steven S Carroll; Osvaldo Flores; Malcolm MacCoss; Daniel R McMasters; Giovanni Migliaccio; David B Olsen
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

3.  Binding-site identification and genotypic profiling of hepatitis C virus polymerase inhibitors.

Authors:  Frederik Pauwels; Wendy Mostmans; Ludo M M Quirynen; Liesbet van der Helm; Carlo W Boutton; Anne-Stéphanie Rueff; Erna Cleiren; Pierre Raboisson; Dominique Surleraux; Origène Nyanguile; Kenneth A Simmen
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

4.  Synergy of a hepatitis C virus (HCV) NS4A antagonist in combination with HCV protease and polymerase inhibitors.

Authors:  David L Wyles; Kelly A Kaihara; Robert T Schooley
Journal:  Antimicrob Agents Chemother       Date:  2008-03-10       Impact factor: 5.191

5.  Structure-based virtual screening, synthesis and SAR of novel inhibitors of hepatitis C virus NS5B polymerase.

Authors:  Tanaji T Talele; Payal Arora; Shridhar S Kulkarni; Maulik R Patel; Satyakam Singh; Maksim Chudayeu; Neerja Kaushik-Basu
Journal:  Bioorg Med Chem       Date:  2010-05-15       Impact factor: 3.641

6.  Combination of pharmacophore hypothesis and molecular docking to identify novel inhibitors of HCV NS5B polymerase.

Authors:  Amaravadhi Harikishore; Enlin Li; Jia Jun Lee; Nam-Joon Cho; Ho Sup Yoon
Journal:  Mol Divers       Date:  2015-04-11       Impact factor: 2.943

7.  Replication fitness and NS5B drug sensitivity of diverse hepatitis C virus isolates characterized by using a transient replication assay.

Authors:  Steven W Ludmerer; Donald J Graham; Evelyn Boots; Edward M Murray; Amy Simcoe; Eric J Markel; Jay A Grobler; Osvaldo A Flores; David B Olsen; Daria J Hazuda; Robert L LaFemina
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

8.  Specific inhibitors of HCV polymerase identified using an NS5B with lower affinity for template/primer substrate.

Authors:  Ginette McKercher; Pierre L Beaulieu; Daniel Lamarre; Steven LaPlante; Sylvain Lefebvre; Charles Pellerin; Louise Thauvette; George Kukolj
Journal:  Nucleic Acids Res       Date:  2004-01-22       Impact factor: 16.971

9.  Inhibitors for the hepatitis C virus RNA polymerase explored by SAR with advanced machine learning methods.

Authors:  Iwona E Weidlich; Igor V Filippov; Jodian Brown; Neerja Kaushik-Basu; Ramalingam Krishnan; Marc C Nicklaus; Ian F Thorpe
Journal:  Bioorg Med Chem       Date:  2013-03-29       Impact factor: 3.641

10.  Comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) of thiazolone derivatives as hepatitis C virus NS5B polymerase allosteric inhibitors.

Authors:  Beilei Lei; Juan Du; Shuyan Li; Huanxiang Liu; Yueying Ren; Xiaojun Yao
Journal:  J Comput Aided Mol Des       Date:  2008-08-21       Impact factor: 3.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.